Clinical Trial Update: MYL-1401A Efficacy and Safety Comparability Study to Humira® [Phase 3]

View source ↗

Summary

Phase 3 trial comparing MYL-1401A to Humira for psoriasis, arthritis, and psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• MYL-1401A

Snippet

Sponsor: Mylan Inc. | Conditions: Psoriasis, Arthritis, Psoriatic | Phase 3 | Status: COMPLETED